Bridgebiocology Therapeut Ownership
$3.89
1.27%
Nasdaq, Oct 02, 04:00 pm EDT.
Closed.
Industry
Bridgebiocology Therapeut Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Cormorant Asset Management, LP
|
17.879m | 22.31% | — | Jul 01 2026 |
| 2 |
BridgeBio Pharma, Inc.
INSIDER
|
14.590m | 18.21% | +784.720k | Oct 10 2025 |
| 3 |
Deerfield Management Company, L.P.
|
4.885m | 6.10% | — | Jun 30 2026 |
| 4 |
BC Global Opportunities IX LP
|
4.366m | 5.45% | +3.266m | Sep 04 2025 |
| 5 |
Omega Fund Management, LLC
|
3.290m | 4.11% | — | Jun 30 2026 |
|
1
Cormorant Asset Management, LP
|
22.31%
17.879m
|
|
2
BridgeBio Pharma, Inc.
INSIDER
|
18.21%
14.590m
|
|
3
Deerfield Management Company, L.P.
|
6.10%
4.885m
|
|
4
BC Global Opportunities IX LP
|
5.45%
4.366m
|
|
5
Omega Fund Management, LLC
|
4.11%
3.290m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 56.18% of Bridgebiocology Therapeut, with Cormorant Asset Management, LP the biggest at 22.31%, followed by BridgeBio Pharma, Inc. (18.21%) and Deerfield Management Company, L.P. (6.10%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
